Company intelligence / Profile preview

BioTron Energy

Ownership: Private
Development stage: Preclinical

Overview

BioTron Energy develops plant-based biopolymer cathodes for primary lithium batteries. Their proprietary material enables significantly higher energy density than current commercial cells. The company holds a non-US patent and has filed for US patent protection. No clinical results are relevant as this is not a healthcare company

Industry: Non-Drug Biotech

Beyond the preview

Go deeper on BioTron Energy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioTron Energy.

Explore the full profile